Blogs

Strong Medicine and Pharma’s Pact with Society: Perspectives from India

GPhA responds to FDA: User fees okay in exchange for more favorable treatment

Dr. Reddy’s buys Betapharm; Could your next job be with an Indian firm?

FDA challenges GPhA and broaches subject of user fees; Biosimilars approval unlikely until 2009

Has anyone seen Michael Moore yet? GSK chief weighs in on Constant Gardener

Progress in Regulatory Harmonization? Europe adopts GMP regulations for APIs

China’s drug market to be fifth largest by 2010; Ranbaxy and Indian drug manufacturers continue to globalize